Jintanat Ananworanich Selected Research

Lipids

1/2017	Carbohydrate, lipid, bone and inflammatory markers in HIV-positive adolescents on antiretroviral therapy and hormonal contraception.
3/2007	Dyslipidemia in an Asian population after treatment for two years with protease inhibitor-containing regimens.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jintanat Ananworanich Research Topics

Disease

64	HIV Infections (HIV Infection) 04/2024 - 02/2005
39	Infections 03/2024 - 08/2006
13	Viremia 02/2024 - 04/2012
12	Acquired Immunodeficiency Syndrome (AIDS) 02/2024 - 03/2009
11	Inflammation (Inflammations) 12/2021 - 01/2016
7	Disease Progression 10/2022 - 05/2007
7	Neurocognitive Disorders (Clerambault Syndrome) 12/2019 - 04/2013
6	Body Weight (Weight, Body) 12/2013 - 11/2005
5	Sexually Transmitted Diseases (Sexually Transmitted Disease) 06/2011 - 09/2003
4	Immune Reconstitution Inflammatory Syndrome 11/2022 - 11/2009
4	Coinfection 09/2020 - 01/2008
4	Cognitive Dysfunction 01/2016 - 01/2013
4	Tuberculosis (Tuberculoses) 04/2014 - 11/2009
3	Hepatitis C 01/2021 - 01/2020
2	Human Influenza (Influenza) 12/2024 - 01/2023
2	Hepatitis B 09/2020 - 05/2013
2	Atrophy 01/2020 - 07/2014
2	Encephalitis (Encephalitis, Rasmussen) 01/2018 - 01/2012
2	Chronic Renal Insufficiency 01/2018 - 09/2014
2	Fibrosis (Cirrhosis) 01/2017 - 01/2014
2	Anemia 01/2017 - 12/2012
2	Liver Diseases (Liver Disease) 01/2014 - 01/2013
2	Neoplasms (Cancer) 12/2013 - 09/2007
2	Exanthema (Rash) 11/2007 - 01/2005
1	COVID-19 01/2022
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Syphilis 01/2021
1	Neurobehavioral Manifestations 01/2021
1	Dysbiosis 12/2020
1	Vaccinia 01/2020
1	Bacterial Vaginosis 11/2018
1	HIV Seropositivity 01/2018
1	Psychomotor Disorders 01/2018
1	Persistent Infection 01/2018

Drug/Important Bio-Agent (IBA)

22	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2008
12	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 01/2013
12	Biomarkers (Surrogate Marker)IBA 12/2020 - 11/2009
9	VaccinesIBA 12/2024 - 10/2008
5	Reverse Transcriptase InhibitorsIBA 10/2012 - 01/2005
5	NucleosidesIBA 01/2011 - 01/2005
4	AntigensIBA 01/2022 - 03/2005
3	Messenger RNA (mRNA)IBA 12/2024 - 01/2013
3	Hemoglobins (Hemoglobin)IBA 09/2020 - 07/2013
3	N-acetyltalosaminuronic acid (NAT)IBA 09/2020 - 10/2008
3	AntibodiesIBA 12/2019 - 05/2013
3	EnzymesIBA 01/2019 - 10/2008
3	Monoclonal AntibodiesIBA 01/2019 - 02/2016
3	Tenofovir (Viread)FDA Link 01/2018 - 01/2008
3	Ritonavir (Norvir)FDA Link 10/2012 - 11/2005
2	Broadly Neutralizing AntibodiesIBA 03/2024 - 05/2015
2	Immunologic Factors (Immunomodulators)IBA 02/2024 - 01/2021
2	dolutegravirIBA 01/2023 - 01/2019
2	efavirenz (Sustiva)FDA Link 01/2023 - 01/2005
2	HLA Antigens (Human Leukocyte Antigens)IBA 10/2022 - 03/2013
2	EpitopesIBA 10/2022 - 01/2021
2	Viral RNAIBA 12/2021 - 11/2021
2	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2021 - 01/2020
2	IntegrinsIBA 12/2020 - 01/2018
2	Chemokine ReceptorsIBA 12/2020 - 05/2007
2	fibrin fragment D (D-dimer)IBA 09/2020 - 01/2017
2	Lipopolysaccharide ReceptorsIBA 09/2020 - 01/2017
2	C-Reactive ProteinIBA 09/2020 - 01/2017
2	Interleukin-6 (Interleukin 6)IBA 09/2020 - 01/2017
2	Emtricitabine (Emtriva)FDA Link 01/2018 - 01/2008
2	Vitamin D FDA LinkGeneric 01/2017 - 01/2014
2	LipidsIBA 01/2017 - 03/2007
2	Protons (Proton)IBA 12/2015 - 01/2012
2	Nucleic AcidsIBA 04/2015 - 10/2008
2	Integrase InhibitorsIBA 01/2015 - 01/2015
2	Raltegravir Potassium FDA Link 01/2015 - 04/2012
2	Nevirapine (Viramune)FDA Link 09/2014 - 01/2005
2	Protease Inhibitors (Protease Inhibitor)IBA 09/2014 - 03/2007
2	Indinavir (Crixivan)FDA Link 10/2012 - 01/2011
2	Saquinavir (Invirase)FDA Link 01/2011 - 11/2005
1	mRNA VaccinesIBA 01/2023
1	mRNA-1010 influenza vaccineIBA 01/2023
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2023
1	Factor Xa InhibitorsIBA 01/2022
1	RivaroxabanIBA 01/2022
1	AnticoagulantsIBA 01/2022
1	Dihydrotachysterol (AT 10)IBA 12/2021
1	ReaginsIBA 01/2021
1	Ribosomal DNA (rDNA)IBA 12/2020
1	Histone Deacetylase InhibitorsIBA 09/2020
1	Interleukin-7 (Interleukin 7)IBA 09/2020
1	Vorinostat FDA Link 09/2020
1	P-selectin ligand proteinIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Explosive Agents (Explosives)IBA 01/2020
1	HIV AntibodiesIBA 12/2019
1	ImmunosorbentsIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	ChemokinesIBA 01/2018

Therapy/Procedure

54	Therapeutics 04/2024 - 09/2003
44	Art Therapy 03/2024 - 01/2008
24	Highly Active Antiretroviral Therapy (HAART) 01/2021 - 02/2005
10	Aftercare (After-Treatment) 02/2024 - 03/2007
2	Hormonal Contraception 01/2017 - 06/2011
2	Condoms (Condom) 08/2016 - 06/2011
1	Copper Intrauterine Devices 11/2018